☰

Jennifer Brooks, Ph.D. - Publications

Affiliations: 
2009 Environmental Health Science New York University, New York, NY, United States 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Christensen RAG, Knight JA, Sutradhar R, Brooks JD. Association between estimated cardiorespiratory fitness and breast cancer: a prospective cohort study. British Journal of Sports Medicine. PMID 37336634 DOI: 10.1136/bjsports-2021-104870  0.355
2023 Brooks JD, Mah A, Christensen RAG, Arneja J, Eisen A, Chiarelli AM. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 25: 100820. PMID 36919844 DOI: 10.1016/j.gim.2023.100820  0.337
2022 Brooks JD, Christensen RAG, Sung JS, Pike MC, Orlow I, Bernstein JL, Morris EA. MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women. Npj Breast Cancer. 8: 97. PMID 36008488 DOI: 10.1038/s41523-022-00458-2  0.331
2022 Watt GP, Knight JA, Nguyen TL, Reiner AS, Malone KE, John EM, Lynch CF, Brooks JD, Woods M, Liang X, Bernstein L, Pike MC, Hopper JL, Bernstein JL. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds. International Journal of Cancer. PMID 35315524 DOI: 10.1002/ijc.34001  0.343
2021 Watt GP, Knight JA, Lin C, Lynch CF, Malone KE, John EM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M, Nguyen TL, Hopper JL, Pike MC, Bernstein JL. Mammographic texture features associated with contralateral breast cancer in the WECARE Study. Npj Breast Cancer. 7: 146. PMID 34845211 DOI: 10.1038/s41523-021-00354-1  0.349
2021 Alarie S, Hagan J, Dalpé G, Faraji S, Mbuya-Bienge C, Nabi H, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L, Turgeon A, Lambert-Côté L, Paquette JS, Walker MJ, et al. Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data. Journal of Personalized Medicine. 11. PMID 34442372 DOI: 10.3390/jpm11080726  0.314
2021 Arneja J, Brooks JD. The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada. Plos One. 16: e0256536. PMID 34437611 DOI: 10.1371/journal.pone.0256536  0.307
2021 Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Després P, Devilee P, Dorval M, Droit A, Easton DF, Eisen A, Eloy L, Fienberg S, Goldgar D, Hahnen E, et al. Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). Journal of Personalized Medicine. 11. PMID 34199804 DOI: 10.3390/jpm11060511  0.331
2020 Watt GP, Sung J, Morris EA, Buys SS, Bradbury AR, Brooks JD, Conant EF, Weinstein SP, Kontos D, Woods M, Colonna SV, Liang X, Stein MA, Pike MC, Bernstein JL. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study. Breast Cancer Research : Bcr. 22: 138. PMID 33287857 DOI: 10.1186/s13058-020-01375-7  0.341
2020 Brooks JD, Boice JD, Shore RE, Reiner AS, Smith SA, Bernstein L, Knight JA, Lynch CF, John EM, Malone KE, Mellemkjær L, Langballe R, Liang X, Woods M, Tischkowitz M, et al. A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study. Breast (Edinburgh, Scotland). 54: 62-69. PMID 32927238 DOI: 10.1016/J.Breast.2020.07.007  0.347
2020 Reiner AS, Robson ME, Mellemkjær L, Tischkowitz M, John EM, Lynch CF, Brooks JD, Boice JD, Knight JA, Teraoka SN, Liang X, Woods M, Shen R, Shore RE, Stram DO, et al. Radiation treatment, ATM, BRCA1/2, and CHEK2*1100delC pathogenic variants, and risk of contralateral breast cancer. Journal of the National Cancer Institute. PMID 32119081 DOI: 10.1093/Jnci/Djaa031  0.352
2019 Watt GP, Reiner AS, Smith SA, Stram DO, Capanu M, Malone KE, Lynch CF, John EM, Knight JA, Mellemkjær L, Bernstein L, Brooks JD, Woods M, Liang X, Haile RW, et al. Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. Jama Network Open. 2: e1912259. PMID 31560388 DOI: 10.1001/jamanetworkopen.2019.12259  0.324
2019 Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, et al. A response to "Personalised medicine and population health: breast and ovarian cancer". Human Genetics. PMID 30810870 DOI: 10.1007/S00439-019-01984-Z  0.372
2018 Brooks JD, Comen EA, Reiner AS, Orlow I, Leong SF, Liang X, Mellemkjær L, Knight JA, Lynch CF, John EM, Bernstein L, Woods M, Doody DR, Malone KE, et al. CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Research : Bcr. 20: 149. PMID 30526633 DOI: 10.1186/S13058-018-1083-Y  0.335
2018 Sung JS, Corben AD, Brooks JD, Edelweiss M, Keating DM, Lin C, Morris EA, Patel P, Robson M, Woods M, Bernstein JL, Pike MC. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI. Breast Cancer Research and Treatment. PMID 30140962 DOI: 10.1007/S10549-018-4916-6  0.34
2018 Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Capanu M, Tischkowitz M, Robson M, Liang X, Woods M, Conti DV, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017773424. PMID 29620998 DOI: 10.1200/Jco.2017.77.3424  0.363
2018 Knight JA, Blackmore KM, Fan J, Malone KE, John EM, Lynch CF, Vachon CM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M, Bernstein JL. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. Breast Cancer Research : Bcr. 20: 23. PMID 29566728 DOI: 10.1186/S13058-018-0948-4  0.329
2017 Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, et al. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Research : Bcr. 19: 83. PMID 28724391 DOI: 10.1186/S13058-017-0874-X  0.379
2017 Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF, Woods M, Liang X, Haile RW, Duggan DJ, Shore RE, et al. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. Journal of the National Cancer Institute. 109. PMID 28521362 DOI: 10.1093/Jnci/Djx051  0.365
2016 Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M, Bernstein JL. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer. Cancer Medicine. PMID 27700016 DOI: 10.1002/Cam4.890  0.329
2016 Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods M, Concannon PJ, Bernstein JL. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. Breast Cancer Research : Bcr. 18: 65. PMID 27400983 DOI: 10.1186/S13058-016-0726-0  0.427
2016 Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, Lee CH, Morris EA, Comstock CE. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results. Radiology. 151419. PMID 27097237 DOI: 10.1148/Radiol.2016151419  0.39
2015 Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. Springerplus. 4: 825. PMID 26751177 DOI: 10.1186/S40064-015-1642-Y  0.334
2014 Iacconi C, Thakur SB, Dershaw DD, Brooks J, Fry CW, Morris EA. Impact of fibroglandular tissue and background parenchymal enhancement on diffusion weighted imaging of breast lesions. European Journal of Radiology. 83: 2137-43. PMID 25445896 DOI: 10.1016/J.Ejrad.2014.09.004  0.343
2013 Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ, Schiermeyer K, Bernstein JL, Figueiredo JC. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes & Control : Ccc. 24: 1605-14. PMID 23775025 DOI: 10.1007/S10552-013-0237-6  0.314
2013 Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P, Schiermeyer K, Lewinger JP, Bernstein JL, Figueiredo JC. Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study. International Journal of Molecular Epidemiology and Genetics. 4: 35-48. PMID 23565321  0.329
2013 Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 433-9. PMID 23269995 DOI: 10.1200/Jco.2012.43.2013  0.348
2013 Gaudet MM, Brooks JD, Robson ME, Bernstein JL. Genetic Epidemiology of Breast Cancer Women and Health. 1113-1125. DOI: 10.1016/B978-0-12-384978-6.00073-X  0.319
2012 King V, Kaplan J, Pike MC, Liberman L, David Dershaw D, Lee CH, Brooks JD, Morris EA. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. The Breast Journal. 18: 527-34. PMID 23002953 DOI: 10.1111/Tbj.12002  0.301
2012 Brooks JD, Boice JD, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, Bernstein JL, Shore RE, et al. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. International Journal of Radiation Oncology, Biology, Physics. 84: 917-24. PMID 22483700 DOI: 10.1016/J.Ijrobp.2012.01.047  0.321
2012 Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD, Lynch CF, Mellemkjaer L, Malone KE, et al. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Human Mutation. 33: 158-64. PMID 21898661 DOI: 10.1002/Humu.21604  0.302
2012 Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, Bernstein JL, Bernstein L. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Research and Treatment. 131: 571-80. PMID 21892703 DOI: 10.1007/S10549-011-1743-4  0.319
2011 King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 260: 50-60. PMID 21493794 DOI: 10.1148/Radiol.11102156  0.334
2010 Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, Zeleniuch-Jacquotte A. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiology. 34: 717-23. PMID 20627767 DOI: 10.1016/J.Canep.2010.05.006  0.492
2009 Brooks J, Cairns P, Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. Cancer Causes & Control : Ccc. 20: 1539-50. PMID 19768562 DOI: 10.1007/S10552-009-9415-Y  0.522
2008 Brooks J, Shore RE, Zeleniuch-Jacquotte A, Currie D, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I. Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1016-9. PMID 18398049 DOI: 10.1158/1055-9965.Epi-08-0065  0.498
Show low-probability matches.